These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33529373)

  • 1. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
    Kayser S; Hills RK; Langova R; Kramer M; Guijarro F; Sustkova Z; Estey EH; Shaw CM; Ráčil Z; Mayer J; Zak P; Baer MR; Brunner AM; Szotkowski T; Cetkovsky P; Grimwade D; Walter RB; Burnett AK; Ho AD; Ehninger G; Müller-Tidow C; Platzbecker U; Thiede C; Röllig C; Schulz A; Warsow G; Brors B; Esteve J; Russell NH; Schlenk RF; Levis MJ
    Br J Haematol; 2021 Mar; 192(5):832-842. PubMed ID: 33529373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.
    Xie W; Hu S; Xu J; Chen Z; Medeiros LJ; Tang G
    Ann Hematol; 2019 May; 98(5):1149-1157. PubMed ID: 30759270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
    Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
    Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
    Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial.
    Zhu HH; Zhang XH; Qin YZ; Liu DH; Jiang H; Chen H; Jiang Q; Xu LP; Lu J; Han W; Bao L; Wang Y; Chen YH; Wang JZ; Wang FR; Lai YY; Chai JY; Wang LR; Liu YR; Liu KY; Jiang B; Huang XJ
    Blood; 2013 May; 121(20):4056-62. PubMed ID: 23535063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
    Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study.
    Kayser S; Hills RK; Luskin MR; Brunner AM; Terré C; Westermann J; Menghrajani K; Shaw C; Baer MR; Elliott MA; Perl AE; Ráčil Z; Mayer J; Zak P; Szotkowski T; de Botton S; Grimwade D; Mayer K; Walter RB; Krämer A; Burnett AK; Ho AD; Platzbecker U; Thiede C; Ehninger G; Stone RM; Röllig C; Tallman MS; Estey EH; Müller-Tidow C; Russell NH; Schlenk RF; Levis MJ
    Haematologica; 2020 Jan; 105(1):161-169. PubMed ID: 31004014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
    Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
    Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission.
    Vasu S; Kohlschmidt J; Mrózek K; Eisfeld AK; Nicolet D; Sterling LJ; Becker H; Metzeler KH; Papaioannou D; Powell BL; Kolitz JE; Moore JO; Baer MR; Roboz GJ; Stone RM; Byrd JC; Carroll AJ; Bloomfield CD
    Blood Adv; 2018 Jul; 2(13):1645-1650. PubMed ID: 29991495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
    Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
    Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21).
    Shao H; Yang Q; Wu C; Cen J; Chen S; Pan J
    Ann Hematol; 2017 Dec; 96(12):2127-2129. PubMed ID: 28840298
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.
    Díaz-Beyá M; Labopin M; Maertens J; Aljurf M; Passweg J; Dietrich B; Schouten H; Socié G; Schaap N; Schwerdtfeger R; Volin L; Michallet M; Polge E; Sierra J; Mohty M; Esteve J; Nagler A;
    Br J Haematol; 2020 Jun; 189(5):920-925. PubMed ID: 32020596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for therapy-related acute myeloid leukaemia (t-AML)--a single centre experience.
    Suvajdžić N; Cvetković Z; Dorđević V; Kraguljac-Kurtović N; Stanisavljević D; Bogdanović A; Djunić I; Colović N; Vidović A; Elezović I; Tomin D
    Biomed Pharmacother; 2012 Jun; 66(4):285-92. PubMed ID: 22401928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission.
    Basara N; Schulze A; Wedding U; Mohren M; Gerhardt A; Junghanss C; Peter N; Dölken G; Becker C; Heyn S; Kliem C; Lange T; Krahl R; Pönisch W; Fricke HJ; Sayer HG; Al-Ali H; Kamprad F; Niederwieser D;
    Leukemia; 2009 Apr; 23(4):635-40. PubMed ID: 19151786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
    Paschka P; Du J; Schlenk RF; Gaidzik VI; Bullinger L; Corbacioglu A; Späth D; Kayser S; Schlegelberger B; Krauter J; Ganser A; Köhne CH; Held G; von Lilienfeld-Toal M; Kirchen H; Rummel M; Götze K; Horst HA; Ringhoffer M; Lübbert M; Wattad M; Salih HR; Kündgen A; Döhner H; Döhner K
    Blood; 2013 Jan; 121(1):170-7. PubMed ID: 23115274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
    Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED
    Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.
    Tang FF; Huang XJ; Zhang XH; Chen H; Chen YH; Han W; Chen Y; Wang FR; Wang Y; Wang JZ; Yan CH; Sun YQ; Mo XD; Liu KY; Xu LP
    Leuk Res; 2016 Aug; 47():8-15. PubMed ID: 27239735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemia.
    Burke MJ; Wagner JE; Cao Q; Ustun C; Verneris MR
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1021-5. PubMed ID: 23567175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.